Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection
about
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Biochemical and structural characterization of WlbA from Bordetella pertussis and Chromobacterium violaceum: enzymes required for the biosynthesis of 2,3-diacetamido-2,3-dideoxy-D-mannuronic acidThe O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunityRediscovering PertussisMolecular Structure of WlbB, a Bacterial N -Acetyltransferase Involved in the Biosynthesis of 2,3-Diacetamido-2,3-dideoxy- d -mannuronic Acid,The route less taken: pulmonary models of enteric Gram-negative infectionIdentification and biochemical characterization of two novel UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronic acid 2-epimerases from respiratory pathogensBiosynthesis of a rare di-N-acetylated sugar in the lipopolysaccharides of both Pseudomonas aeruginosa and Bordetella pertussis occurs via an identical scheme despite different gene clustersA deep rough type structure in Bordetella bronchiseptica lipopolysaccharide modulates host immune responses.Modeling systems-level regulation of host immune responses.O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.Cyclic-di-GMP signalling regulates motility and biofilm formation in Bordetella bronchiseptica.Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussisAntigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic.Use of bacteriophage Ba1 to identify properties associated with Bordetella avium virulence.In vitro and in vivo characterization of a Bordetella bronchiseptica mutant strain with a deep rough lipopolysaccharide structure.Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation.Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens.The AS87_04050 gene is involved in bacterial lipopolysaccharide biosynthesis and pathogenicity of Riemerella anatipestiferThe Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.sigE facilitates the adaptation of Bordetella bronchiseptica to stress conditions and lethal infection in immunocompromised miceInterleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.Role of Bordetella O antigen in respiratory tract infection.Enhanced biofilm formation by Escherichia coli LPS mutants defective in Hep biosynthesisDifferential expression of alpha 4 integrins on effector memory T helper cells during Bordetella infections. Delayed responses in Bordetella pertussisRole of pagL and lpxO in Bordetella bronchiseptica lipid A biosynthesisPorphyromonas gingivalis galE is involved in lipopolysaccharide O-antigen synthesis and biofilm formationRecommendation for a Standardised Method of Broth Microdilution Susceptibility Testing for Porcine Bordetella bronchiseptica.Genomic features of Bordetella parapertussis clades with distinct host species specificityHost Specificity of Ovine Bordetella parapertussis and the Role of ComplementHomologs of the LapD-LapG c-di-GMP Effector System Control Biofilm Formation by Bordetella bronchiseptica.Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infectiIs there a need for a new generation of vaccines against pertussis?Genome characterization and population genetic structure of the zoonotic pathogen, Streptococcus canis.Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- miceTranscriptional and translational analysis of biofilm determinants of Aggregatibacter actinomycetemcomitans in response to environmental perturbationEvidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica.Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica.Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract.
P2860
Q24522458-7BB26DDA-6FFA-4510-8F12-B4DC35279AAAQ24606876-AD3681D2-75F1-4824-80A2-A13557A36C94Q24672570-A7C4493B-5CD1-4BAF-AF58-85F447E243E2Q26744793-DC7CFEDD-D95A-446A-A4D7-B6B96B6040ECQ27661069-0F3ECAB8-E8E1-4877-B4CA-0F6B98FA8711Q27691303-DCD38E1E-AC5C-44E2-9472-CEF00AF63EC9Q28493126-F4EF62B7-5207-459F-9428-9640D08F29E5Q28493222-72F98D29-6686-47FC-B00F-26AEE3370B68Q31039926-4FC857B9-4AE5-436C-B9B7-1558889167FFQ33287189-1CDBE909-FFE4-44C5-BED4-EB48BB2ED612Q33502706-646BD570-F9BF-47AC-B7F5-F82845BCCF32Q33860272-0CF08DD6-6E62-4AE3-9243-B0DE431E56A6Q33999534-CC52F6E7-4EDD-433F-AC77-F0A49D6126EAQ34094342-A15FCD2F-1F7F-4389-AD8F-280B355F73D2Q34120377-83D58C2C-BE47-45C4-B30F-296013B0F50CQ34120683-64D0A4BA-EA44-4391-9963-1BFE92C8E5D6Q34197176-EC273835-B867-4C4E-8333-95C91AA92128Q34197263-CFC9F631-1DF8-46E0-ACDE-7B75066878C1Q34323518-4B3FF508-972A-446A-BEF6-18A3947F1483Q34334393-6F057DBE-A8C4-443B-A1EC-CC3099BEC54AQ34381822-B317B2A2-68B4-4245-A88F-F297190BFEB9Q34484529-15F35E22-8593-4EFE-865D-9209621213A7Q34531338-A4E75CFA-4B8D-4195-B415-337230913042Q34531717-AFD35711-E080-464D-8AF9-F3C8E8F5EEC9Q34541373-28FA1A6F-25EB-466C-BC8C-0AAB827A9C24Q35192421-E04F9384-032E-426A-A314-3132E4A89D63Q35217619-A7C55EE9-6E9B-4A1B-960E-29A261CF5062Q35614052-122FB387-41C0-4337-BE07-090CDE5E5950Q35630206-139CC112-B04D-43B6-9A18-A6E536804370Q35687017-D521E729-4D9A-41DC-A2E0-C966927EB0B1Q36068387-E44F29D1-24A2-4FDD-8D85-71EDBB721631Q36109040-867066C3-0AB1-4721-AAB9-ACA392951165Q36174557-7025F17E-2274-48F1-9FB9-00A1077C9530Q36458388-2F5FC938-B0DC-41E8-8801-020EC3A5AAEFQ36521441-147A3685-C4DB-4F98-8658-41105544B113Q36746359-46DFF120-E48E-48B9-A5BB-8EFDE1DE67CCQ37256474-7506CEC9-23E2-4BE8-B7E4-5D19B3F0F31BQ37274891-9016A696-3012-4797-A924-E897DEB787D4Q37333410-C4CE31CF-1619-4FE5-A547-58D3CAA06787Q37523902-52010163-3322-464A-A93D-B54DC8DFE64F
P2860
Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Multiple roles for Bordetella ...... ng respiratory tract infection
@ast
Multiple roles for Bordetella ...... ng respiratory tract infection
@en
Multiple roles for Bordetella ...... ng respiratory tract infection
@nl
type
label
Multiple roles for Bordetella ...... ng respiratory tract infection
@ast
Multiple roles for Bordetella ...... ng respiratory tract infection
@en
Multiple roles for Bordetella ...... ng respiratory tract infection
@nl
prefLabel
Multiple roles for Bordetella ...... ng respiratory tract infection
@ast
Multiple roles for Bordetella ...... ng respiratory tract infection
@en
Multiple roles for Bordetella ...... ng respiratory tract infection
@nl
P2093
P2860
P1476
Multiple roles for Bordetella ...... ng respiratory tract infection
@en
P2093
D J Maskell
E T Harvill
J F Miller
P A Cotter
P2860
P304
P356
10.1128/IAI.68.12.6720-6728.2000
P407
P577
2000-12-01T00:00:00Z